The insulin sensitivity concept;Le concept d'insulinosensibilité

Diabetes and Metabolism

Volumn 27, Issue 2 II, 2001, Pages 193-200

  Scheen, A J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Atherosclerosis; Insulin resistance; Obesity; Thiazolidinediones; Type 2 diabetes

Indexed keywords

ACARBOSE; GLUCOSE; INSULIN; METFORMIN; MIGLITOL; SULFANILAMIDE; THIAZOLIDINE DERIVATIVE;

ANALYTIC METHOD; ARTICLE; ATHEROSCLEROSIS; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; SYNDROME X;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; OBESITY; RISK FACTORS; SYNDROME;

EID: 0035040502     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Diabetes mellitus. Its differentiation into insulin-sensitive and insulin-insensitive types
2. Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determination by a new sensitive immunoassay technique
3. Assessment of insulin sensitivity in vivo
4. How to measure insulin action in vivo
5. Comment évaluer la sensibilité à l'insuline en pratique?
6. Comment apprécier chez l'homme l'action de l'insuline en recherche et en pratique
7. Consensus Development Conference on insulin resistance
8. Role of insulin resistance in human disease
9. Insulin resistance and disease
10. Insulin action in man
11. Control of glycaemia
12. Molecular basis of insulin action
13. Signalisation de l'insuline et mécanismes moléculaires de l'insulinorésistance
14. Modeling of insulin action in vivo
15. Insulin resistance, insulin sensitivity, and insulin unresponsiveness: A necessary distinction
16. Pathophysiology of insulin resistance in human disease
17. Role of free fatty acids in insulin resistance of subjects with non-insulin-dependent diabetes
18. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
19. 13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents
20. Tumor necrosis factor. A key component of the obesity-diabetes link
21. Relation between leptin and the regulation of glucose metabolism
22. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
23. Vascular defects in the aetiology of peripheral insulin resistance in diabetes. A critical review of hypotheses and facts
24. Clustering of hypertension, diabetes, and obesity in adult male twins: Same genes or same environments?
25. Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes
26. Genetics and the metabolic syndrome
27. Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis
28. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth
29. Growth in utero and coronary heart disease
30. Glucose toxicity
31. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications
32. Pathophysiology of Type 2 diabetes
33. Post-gastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women
34. Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity
35. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: The Bogalusa Heart Study
36. Assessment of insulin resistance in vivo. Application to the study of type 2 diabetes
37. Role of insulin resistance in the pathogenesis of NIDDM
38. Insulinorésistance: Quel rôle dans le diabète de type 2?
39. Insulin resistance versus insulin deficiency: Which one comes first? The old question revisited
40. Improving the action of insulin
41. Management of the obese diabetic patient
42. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
43. Insulin sensitivity and atherosclerosis
44. Insulin resistance and atherosclerosis
45. Role of insulin resistance in human disease (syndrome X): An expanded definition
46. Insulin resistance: The clinical spectrum
47. Abdominal obesity as an important component of insulin-resistance syndrome
48. Relation between obesity from childhood to adulthood and the metabolic syndrome: Population based study
49. Type 2 diabetes care: The role of insulin-sensitizing agents and practical implications for cardiovascular disease prevention
50. Antidiabetic drugs present and future: Will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus?
51. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states
52. Perspective in the treatment of insulin resistance
53. Metformin: A review of its metabolic effects
54. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
55. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
56. Troglitazone: Antihyperglycemic activity and potential role in the treatment of type 2 diabetes
57. Metabolic and vascular effects of the thiazolidinedione troglitazone
58. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes